ORION BIOTECH OPPORTUNTES CO's ticker is ORIAW and the CUSIP is G6780C117. A total of 32 filers reported holding ORION BIOTECH OPPORTUNTES CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $7,060 | -56.8% | 100,000 | 0.0% | 0.00% | – |
Q4 2022 | $16,340 | -9.2% | 100,000 | 0.0% | 0.00% | – |
Q3 2022 | $18,000 | +12.5% | 100,000 | 0.0% | 0.00% | – |
Q2 2022 | $16,000 | -56.8% | 100,000 | 0.0% | 0.00% | – |
Q1 2022 | $37,000 | – | 100,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ANGELO GORDON & CO., L.P. | 60,000 | $590,000 | 0.03% |
Radcliffe Capital Management, L.P. | 80,000 | $782,000 | 0.02% |
Anson Funds Management LP | 15,000 | $147,000 | 0.01% |
Atalaya Capital Management LP | 100,000 | $87,000 | 0.01% |
MMCAP International Inc. SPC | 160,000 | $139,000 | 0.01% |
Segantii Capital Management Ltd | 30,000 | $295,000 | 0.01% |
Arena Capital Advisors, LLC- CA | 120,000 | $105,000 | 0.01% |
683 Capital Management, LLC | 239,800 | $209,000 | 0.01% |
SPRING CREEK CAPITAL LLC | 160,000 | $140,000 | 0.01% |
FIR TREE CAPITAL MANAGEMENT LP | 200,000 | $175,000 | 0.01% |